• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预后营养指数与慢性肝病患者的肝功能及预后相关。

Prognostic Nutritional Index Correlates with Liver Function and Prognosis in Chronic Liver Disease Patients.

作者信息

Matsui Masahiro, Asai Akira, Ushiro Kosuke, Onishi Saori, Nishikawa Tomohiro, Ohama Hideko, Tsuchimoto Yusuke, Kim Soo Ki, Nishikawa Hiroki

机构信息

The Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Osaka, Japan.

Liver Center, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Osaka, Japan.

出版信息

Diagnostics (Basel). 2023 Dec 25;14(1):49. doi: 10.3390/diagnostics14010049.

DOI:10.3390/diagnostics14010049
PMID:38201358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10802838/
Abstract

The Prognostic Nutritional Index (PNI) is widely recognized as a screening tool for nutrition. We retrospectively examined the impact of PNI in patients with chronic liver disease (CLD, = 319, median age = 71 years, 153 hepatocellular carcinoma (HCC) patients) as an observational study. Factors associated with PNI < 40 were also examined. The PNI correlated well with the albumin-bilirubin (ALBI) score and ALBI grade. The 1-year cumulative overall survival rates in patients with PNI ≥ 40 ( = 225) and PNI < 40 ( = 94) were 93.2% and 65.5%, respectively ( < 0.0001). In patients with ( < 0.0001) and without ( < 0.0001) HCC, similar tendencies were found. In the multivariate analysis, hemoglobin ( = 0.00178), the presence of HCC ( = 0.0426), and ALBI score ( < 0.0001) were independent factors linked to PNI < 40. Receiver operating characteristic (ROC) curve analysis based on survival for the PNI yielded an area under the ROC curve of 0.79, with sensitivity of 0.80, specificity of 0.70, and an optimal cutoff point of 42.35. In conclusion, PNI can be a predictor of nutritional status in CLD patients. A PNI of <40 can be useful in predicting the prognosis of patients with CLD.

摘要

预后营养指数(PNI)被广泛认为是一种营养筛查工具。作为一项观察性研究,我们回顾性研究了PNI对慢性肝病(CLD,n = 319,中位年龄 = 71岁,153例肝细胞癌(HCC)患者)患者的影响。还研究了与PNI < 40相关的因素。PNI与白蛋白-胆红素(ALBI)评分和ALBI分级密切相关。PNI≥40(n = 225)和PNI < 40(n = 94)患者的1年累积总生存率分别为93.2%和65.5%(P < 0.0001)。在有(P < 0.0001)和无(P < 0.0001)HCC的患者中也发现了类似趋势。在多变量分析中,血红蛋白(P = 0.00178)、HCC的存在(P = 0.0426)和ALBI评分(P < 0.0001)是与PNI < 40相关的独立因素。基于PNI生存情况的受试者工作特征(ROC)曲线分析得出ROC曲线下面积为0.79,灵敏度为0.80,特异性为0.70,最佳截断点为42.35。总之,PNI可作为CLD患者营养状况的预测指标。PNI < 40有助于预测CLD患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4759/10802838/b3b80a7787ac/diagnostics-14-00049-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4759/10802838/de5cfbf3c4e5/diagnostics-14-00049-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4759/10802838/91d138e05a9a/diagnostics-14-00049-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4759/10802838/74ee7b8a0695/diagnostics-14-00049-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4759/10802838/b3b80a7787ac/diagnostics-14-00049-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4759/10802838/de5cfbf3c4e5/diagnostics-14-00049-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4759/10802838/91d138e05a9a/diagnostics-14-00049-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4759/10802838/74ee7b8a0695/diagnostics-14-00049-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4759/10802838/b3b80a7787ac/diagnostics-14-00049-g004a.jpg

相似文献

1
Prognostic Nutritional Index Correlates with Liver Function and Prognosis in Chronic Liver Disease Patients.预后营养指数与慢性肝病患者的肝功能及预后相关。
Diagnostics (Basel). 2023 Dec 25;14(1):49. doi: 10.3390/diagnostics14010049.
2
Combined prognostic nutritional index and albumin-bilirubin grade to predict the postoperative prognosis of HBV-associated hepatocellular carcinoma patients.联合预后营养指数和白蛋白-胆红素分级预测乙肝相关肝细胞癌患者的术后预后。
Sci Rep. 2021 Jul 16;11(1):14624. doi: 10.1038/s41598-021-94035-5.
3
Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma.营养指数作为不可切除肝细胞癌患者仑伐替尼治疗的预后指标。
Oncology. 2020;98(5):295-302. doi: 10.1159/000506293. Epub 2020 Feb 25.
4
Prognostic nutritional index predicts short-term outcomes after liver resection for hepatocellular carcinoma within the Milan criteria.预后营养指数可预测米兰标准内肝细胞癌肝切除术后的短期预后。
Oncotarget. 2016 Dec 6;7(49):81611-81620. doi: 10.18632/oncotarget.13151.
5
Prediction Efficacy of Prognostic Nutritional Index and Albumin-Bilirubin Grade in Patients With Intrahepatic Cholangiocarcinoma After Radical Resection: A Multi-Institutional Analysis of 535 Patients.预后营养指数和白蛋白-胆红素分级对肝内胆管癌根治性切除术后患者的预测效能:一项对535例患者的多机构分析
Front Oncol. 2021 Dec 10;11:769696. doi: 10.3389/fonc.2021.769696. eCollection 2021.
6
Refining Prognosis in Chemoembolization for Hepatocellular Carcinoma: Immunonutrition and Liver Function.肝细胞癌化疗栓塞预后的优化:免疫营养与肝功能
Cancers (Basel). 2021 Aug 5;13(16):3961. doi: 10.3390/cancers13163961.
7
Preoperative Albumin-Bilirubin Grade With Prognostic Nutritional Index Predicts the Outcome of Patients With Early-Stage Hepatocellular Carcinoma After Percutaneous Radiofrequency Ablation.术前白蛋白-胆红素分级联合预后营养指数可预测早期肝细胞癌患者经皮射频消融术后的结局。
Front Med (Lausanne). 2020 Nov 10;7:584871. doi: 10.3389/fmed.2020.584871. eCollection 2020.
8
Prognostic Value of the Systemic Immune-Inflammation Index and Prognostic Nutritional Index in Patients With Medulloblastoma Undergoing Surgical Resection.全身免疫炎症指数和预后营养指数在接受手术切除的髓母细胞瘤患者中的预后价值
Front Nutr. 2021 Dec 17;8:754958. doi: 10.3389/fnut.2021.754958. eCollection 2021.
9
Comparison between Child-Pugh score and Albumin-Bilirubin grade in the prognosis of patients with HCC after liver resection using time-dependent ROC.使用时间依赖性ROC比较Child-Pugh评分与白蛋白-胆红素分级在肝癌肝切除术后患者预后中的差异。
Ann Transl Med. 2020 Apr;8(8):539. doi: 10.21037/atm.2020.02.85.
10
Clinical efficacy of Mac-2-binding protein glycosylation isomer as a biomarker for albumin-bilirubin grade and the Controlling Nutritional Status score in chronic liver disease: investigation of cut-off values by the type of chronic liver disease.Mac-2 结合蛋白糖基化异构体作为慢性肝病白蛋白-胆红素分级和控制营养状况评分生物标志物的临床疗效:按慢性肝病类型探讨截断值。
Ann Palliat Med. 2022 Aug;11(8):2658-2667. doi: 10.21037/apm-22-270. Epub 2022 Jul 1.

引用本文的文献

1
Joint effects of prognostic nutritional index and skeletal muscle index on prognosis of decompensated cirrhosis: a retrospective cohort study.预后营养指数和骨骼肌指数对失代偿期肝硬化预后的联合影响:一项回顾性队列研究
Ther Adv Chronic Dis. 2025 Sep 3;16:20406223251369763. doi: 10.1177/20406223251369763. eCollection 2025.
2
Association of prognostic nutritional index with all-cause mortality and cardiovascular mortality: a nationwide population-based cohort study.预后营养指数与全因死亡率和心血管死亡率的关联:一项基于全国人群的队列研究。
Front Nutr. 2025 Jul 14;12:1530452. doi: 10.3389/fnut.2025.1530452. eCollection 2025.
3

本文引用的文献

1
Combined use of handgrip strength and hemoglobin as markers of undernutrition in patients with stage 3-5 chronic kidney disease.联合使用握力和血红蛋白作为3-5期慢性肾病患者营养不良的标志物。
Nutr Metab Cardiovasc Dis. 2023 Nov;33(11):2169-2178. doi: 10.1016/j.numecd.2023.06.015. Epub 2023 Jun 22.
2
Prognostic nutritional index: A potential biomarker for predicting the prognosis of decompensated liver cirrhosis.预后营养指数:一种预测失代偿期肝硬化预后的潜在生物标志物。
Front Nutr. 2023 Jan 6;9:1092059. doi: 10.3389/fnut.2022.1092059. eCollection 2022.
3
Nutritional status in patients with hepatocellular carcinoma: Potential relevance for clinical outcome.
Malnutrition-Related Liver Steatosis, CONUT Score and Poor Clinical Outcomes in an Internal Medicine Department.
内科营养不良相关性肝脂肪变性、CONUT 评分与不良临床结局。
Nutrients. 2024 Jun 18;16(12):1925. doi: 10.3390/nu16121925.
肝细胞癌患者的营养状况:对临床结局的潜在相关性。
Eur J Intern Med. 2022 Oct;104:80-88. doi: 10.1016/j.ejim.2022.07.002. Epub 2022 Jul 26.
4
A detailed assessment of liver function in patients with hepatocellular carcinoma via the modified albumin-bilirubin (mALBI) grade.通过改良白蛋白-胆红素(mALBI)分级对肝细胞癌患者的肝功能进行详细评估。
Am J Cancer Res. 2022 Jun 15;12(6):2711-2720. eCollection 2022.
5
Nutrition as Therapy in Liver Disease.营养疗法在肝脏疾病中的应用。
Clin Ther. 2022 May;44(5):682-696. doi: 10.1016/j.clinthera.2022.04.012. Epub 2022 May 25.
6
Grip Strength in Patients with Gastrointestinal Diseases.胃肠道疾病患者的握力
J Clin Med. 2022 Apr 7;11(8):2079. doi: 10.3390/jcm11082079.
7
The Relationship between the SARC-F Score and the Controlling Nutritional Status Score in Gastrointestinal Diseases.胃肠道疾病中SARC-F评分与控制营养状况评分之间的关系
J Clin Med. 2022 Jan 24;11(3):582. doi: 10.3390/jcm11030582.
8
Prognostic Impact of the SARC-F Score in Gastrointestinal Advanced Cancers.SARC-F评分对胃肠道晚期癌症的预后影响
Cancers (Basel). 2021 Dec 21;14(1):10. doi: 10.3390/cancers14010010.
9
Comparison of SARC-F Score among Gastrointestinal Diseases.胃肠道疾病中SARC-F评分的比较
J Clin Med. 2021 Sep 10;10(18):4099. doi: 10.3390/jcm10184099.
10
Malnutrition and liver disease in a developing country.发展中国家的营养不良与肝病。
World J Gastroenterol. 2021 Aug 14;27(30):4985-4998. doi: 10.3748/wjg.v27.i30.4985.